Novel degraders show promise in preclinical studies
Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at…
Epigenetic plasticity in germinal center B cells may help explain lymphoma origins
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During…
Researchers unravel why mRNA-based vaccines for COVID-19 can cause heart damage
Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause heart damage…
How tick saliva reprograms the skin’s immune defenses
A research team led by the Medical University of Vienna has gained new insights into how ticks influence…
Hematological and biochemical indicators show growing value in breast cancer management
Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to…
Intranasal nanomedicine shows promise against glioblastoma
Researchers at Washington University School of Medicine in St. Louis, along with collaborators at Northwestern University, have developed…
T cells drive vaccine effectiveness against porcine reproductive and respiratory syndrome virus
A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV)…
Personalized prehabilitation reduces the risk of surgical complications
The weeks leading up to a major surgery can be a time of uncertainty and worry for patients,…
Trojan horse strategy using cesium nanosalts shows powerful anti-cancer effects
Recently, a team led by Academician Hongjie Zhang, Researcher Shuyan Song, Associate Researcher Pengpeng Lei, and Dr. Ran An…
Researchers develop a novel approach to monitor CD8⁺ T cell activity over time
The ability of immune cells-particularly CD8+ T cells-to launch a rapid burst of proliferation inside tumors is key…
Engineered Salmonella therapy delivers immune payloads to combat cancer
A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled “ACTM-838, a novel systemically delivered…
World’s first vaccine trial against elephant endotheliotropic herpesvirus proves safe and effective
The world’s first vaccine trial against elephant endotheliotropic herpesvirus (EEHV) – a leading cause of death in young…